Coya Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Coya Therapeutics, Inc. (COYA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $5.28 per share as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2026-08-11
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $5.28.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $5.29.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $5.44.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $5.44.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $5.28 10-Q · filed 2026-08-11 |
| 2026-03-31 | $5.29 10-Q · filed 2026-05-12 |
| 2025-12-31 | $5.44 10-K · filed 2026-03-16 |
| 2025-09-30 | $5.44 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.41 10-Q · filed 2025-08-12 |
| 2025-03-31 | $5.37 10-Q · filed 2025-05-13 |
| 2024-12-31 | $5.07 10-K · filed 2025-03-18 |
| 2024-09-30 | $5.07 10-Q · filed 2024-11-06 |
| 2024-06-30 | $5.06 10-Q · filed 2024-08-12 |
| 2024-03-31 | $4.18 10-Q · filed 2024-05-09 |
| 2023-12-31 | $3.24 10-K · filed 2024-03-19 |
| 2023-09-30 | $3.11 10-Q · filed 2023-11-08 |
| 2023-06-30 | $3.02 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.90 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.85 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |